[64Cu]Cu-AKY-1189

N/A

Report date: 2025/11/21 17:16:21

Base Information

Drug Name[64Cu]Cu-AKY-1189

Drug Alias Name[64Cu]Cu-AKY-1189

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionRadionuclide imaging enhancersNectin-4 modulators

TargetsNectin-4

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAktis Oncology Inc

China Registration ClassN/A

Develop Information

Active CompaniesAktis Oncology Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A